Letter to the editor: "Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine"

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 303, Issue 6, 2012, Pages

  Großkopf, Henning ^a   Böhmer, Anke ^a   Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINE; DIMETHYLAMINE; DIMETHYLARGININASE; HEMOGLOBIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE;

BIOSYNTHESIS; CARDIOVASCULAR RISK; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; GAS CHROMATOGRAPHY; HEMOLYSIS; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEOMICS; TANDEM MASS SPECTROMETRY; ULTRAFILTRATION;

ARGININE; ERYTHROCYTES; FEMALE; HUMANS; MALE;

EID: 84866371644     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00449.2012     Document Type: Letter

References (10)

1. Böhmer A, Großkopf H, Jordan J, Tsikas D. Human hemoglobin does not contain asymmetric dimethylarginine (ADMA). Nitric Oxide 27: 72-74, 2012.
2. Chobanyan K, Thum T, Suchy MT, Zhu B, Mitschke A, Gutzki FM, Beckmann B, Stichtenoth DO, Tsikas D. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): Evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans. J Chromatogr B Analyt Technol Biomed Life Sci 858: 32-41, 2007.
3. D'Alecy LG, Billecke SS. Massive quantities of asymmetric dimethylarginine (ADMA) are incorporated in red blood cell proteins and may be released by proteolysis following hemolytic stress. Blood Cells Mol Dis 45: 40, 2010.
4. Davids M, van Hell AJ, Visser M, Nijveldt RJ, van Leeuwen PA, Teerlink T. Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine. Am J Physiol Heart Circ Physiol 302: H1762-H1770, 2012.
5. Kang ES, Cates TB, harper DN, Chiang TM, Myers LK, Acchiardo SR, Kimoto M. An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells. Free Radic Res 35: 693-707, 2011.
6. Lenzen H, Tsikas D, Böger RH. Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease. The multicenter CARDIAC study. Eur J Clin Pharmacol 62: 45-49, 2006.
7. Pasini EM, Kirkegaard M, Mortensen P, Lutz HU, Thomas AW, Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108: 791-801, 2006.
8. Tsikas D, Böger RH, Sandmann J, Bode-Böger SM, Frölich JC. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett 478: 1-3, 2000.
9. Tsikas D, Schubert B, Gutzki FM, Sandmann J, Schwedhelm E, Frölich JC. Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B Analyt Technol Biomed Life Sci 798: 87-99, 2003.
10. Zinellu A, Sotgia S, Scanu B, Deiana L, Carru C. Determination of protein-incorporated methylated arginine reference values in healthy subjects whole blood and evaluation of factors affecting protein methylation. Clin Biochem 41: 1218-1223, 2008.